Rosen Firm is at it again. This time they are going after Neurotrope NTRP, a company that is trying to develop an Alzheimer's drug that is NOT based on the same failed ideas of every other Alzheimer's drug. (NONE of the drugs that are used now for Alzheimer's are more than very minimally effective, for a very short period of time -- and at great expense.)

http://www.prnewswire.com/news-releases/equit...83613.html